Related Experiment Video

Updated: Jul 4, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Management of dyslipidaemia - evidence and practical recommendations

Paul J Nestel1, Richard O'Brien, Mark Nelson

  • 1Cardiovascular Nutrition Laboratory, Baker Heart Research Institute, Melbourne, Victoria.

Australian Family Physician
|July 2, 2008
PubMed

Insights

Managing dyslipidaemia in general practice requires identifying cardiovascular disease (CVD) risk using absolute risk assessment. Active treatment is recommended for those with a >15% 5-year CVD risk, with drug therapy considered for 10-15% risk groups.

Area of Science:

  • General Practice
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Dyslipidaemia is a prevalent condition frequently encountered in primary care settings.
  • Effective management of dyslipidaemia is crucial for cardiovascular disease (CVD) prevention.

Purpose of the Study:

  • To review current evidence on dyslipidaemia management.
  • To provide practical guidance for general practitioners on managing dyslipidaemia.
  • To outline strategies for identifying and treating individuals at risk of CVD.

Main Methods:

  • Review of existing scientific literature and clinical guidelines.
  • Emphasis on absolute cardiovascular risk assessment.
  • Consideration of lipid targets including LDL-c, HDL-c, and triglycerides.

Main Results:

  • Absolute risk assessment is the preferred method for identifying individuals at elevated risk of CVD.
  • Individuals with a >15% absolute risk of a cardiovascular event within 5 years warrant active treatment.
  • Drug therapy should be considered for those with a 10-15% 5-year CVD risk, especially with additional risk factors.

Conclusions:

  • Early identification and intervention for dyslipidaemia are essential for CVD risk reduction.
  • Tailored lipid-lowering therapies, considering LDL-c, HDL-c, and triglycerides, are necessary to achieve treatment goals.
  • Lifestyle modifications should be integrated as a foundational element of all dyslipidaemia management plans.
Abstract

More Related Videos

Assessing Whole-Body Lipid-Handling Capacity in Mice07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...